(Total Views: 631)
Posted On: 08/11/2020 9:39:37 AM
Post# of 149009
OK,
We got the news !!!
Is this what I think it is ?????
We have a p-value @day 14 of 0.0223 in NEWS score. This is being used as an endpoint in several other COVID-19 clinical trials.
So, apparently the news are good. We can go for NEWS if FDA wants a P3. Remains to be seen what are the numbers for the original score. More details to follow according to release.
In general, I think we will have very meaningful data !!!.
We got the news !!!
Quote:
In all treated patients, at the End of Treatment (or Day 14), patients in the leronlimab group were more than twice as likely to experience a beneficial improvement in scores compared to patients in the placebo group (50% vs 20%; p=0.0223).
Similar, statistically significant, results were observed at Day 3 and Day 14 in the analysis of per protocol population (p<0.03 and p<0.02, respectively).
Is this what I think it is ?????
We have a p-value @day 14 of 0.0223 in NEWS score. This is being used as an endpoint in several other COVID-19 clinical trials.
So, apparently the news are good. We can go for NEWS if FDA wants a P3. Remains to be seen what are the numbers for the original score. More details to follow according to release.
In general, I think we will have very meaningful data !!!.
(3)
(0)Scroll down for more posts ▼
